Regeneron Pharmaceuticals

Regeneron Pharmaceuticals, Inc. is

a biotechnology company headquartered in Tarrytown, New
York. The company was founded in 1988.[3] Originally focused
on neurotrophic factors and their regenerative capabilities (thus
the name), it branched out into the study of
both cytokine and tyrosine kinase receptors.

Type Public

 NASDAQ: REGN
Traded as
 NASDAQ-100 component
 S&P 500 component

Industry Pharmaceuticals; Biotech

Founded 1988

Headquarters Tarrytown, New York, US(Headquarters)

Area served Worldwide

Key people  Leonard Schleifer (CEO)

 George Yancopoulos, CSO

Revenue $4.1 billion[1]

Net income $1.4 billion[1]

Total assets $5.6 billion[1]

 Owner Sanofi[2] (22.6%)

Website www.regeneron.com

Rank last year

85
Years on list
4
HQ location
Tarrytown, N.Y.
Employees
6323
Job openings (as of February 2018)
534
Industry
Biotechnology & Pharmaceuticals
Revenue, 2017 or most recent year ($M)
$4,860
Year founded
1988
Type of organization
Public
Number of work sites
3
Website
http://www.regeneron.com